14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies
In-Person Event
Feb 10, 2018
New York City, New York, USA
OVERVIEW
14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies is organized by Physicians Education Resource LLC (PER) and will be held on Feb 10, 2018 at InterContinental New York Times Square, New York City, New York, United States Of America.
The target audience for this medical event is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate. This CME Conference has been approved for a maximum of 6.75 CME Credits.
PER’s 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational conference, revolutionizing the presentation of emerging therapies and evolving standards of care in the management of patients with melanoma and other cutaneous malignancies.
This year’s symposium will once again feature the dynamic and interactive Medical Crossfire® format, where experts will engage in a rigorous debate to answer your questions, and reach consensus on ongoing paradigm shifts. This fast-paced and interactive forum will once again prove highly practical to physicians who treat patients with skin cancer and provide them with unmatched access to the leading experts. Join us in New York, and together, we’ll meet the challenges currently facing the field!
What you will learn at the International Symposium on Melanoma!
• The latest strategies on checkpoint inhibitor strategies, when to use single-agent or combination regiments.
• Insights into the role of other immunotherapy targets including OX40, GITR, IDO, and more.
• Current and emerging combinations to treat BRAF-mutant melanoma
• Expert perspectives on the management of regional disease and how to prevent recurrence.
• Evolving strategies to mitigate treatment-related toxicities with targeted and immunotherapies.
Learning Objectives
At the conclusion of this symposium, you should be better prepared to:
• Choose treatment based on patient characteristics, such as age and performance status.
• Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients.
• Review strategies for mitigating and managing adverse events related to therapy.
• Describe current and emerging strategies for individualizing therapy.
• Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies.
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate. This CME Conference has been approved for a maximum of 6.75 CME Credits.
PER’s 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational conference, revolutionizing the presentation of emerging therapies and evolving standards of care in the management of patients with melanoma and other cutaneous malignancies.
This year’s symposium will once again feature the dynamic and interactive Medical Crossfire® format, where experts will engage in a rigorous debate to answer your questions, and reach consensus on ongoing paradigm shifts. This fast-paced and interactive forum will once again prove highly practical to physicians who treat patients with skin cancer and provide them with unmatched access to the leading experts. Join us in New York, and together, we’ll meet the challenges currently facing the field!
What you will learn at the International Symposium on Melanoma!
• The latest strategies on checkpoint inhibitor strategies, when to use single-agent or combination regiments.
• Insights into the role of other immunotherapy targets including OX40, GITR, IDO, and more.
• Current and emerging combinations to treat BRAF-mutant melanoma
• Expert perspectives on the management of regional disease and how to prevent recurrence.
• Evolving strategies to mitigate treatment-related toxicities with targeted and immunotherapies.
Learning Objectives
At the conclusion of this symposium, you should be better prepared to:
• Choose treatment based on patient characteristics, such as age and performance status.
• Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients.
• Review strategies for mitigating and managing adverse events related to therapy.
• Describe current and emerging strategies for individualizing therapy.
• Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies.
Additional details will be posted as soon as they are available.
KEY DATES
10 Feb, 2018
Event Start Date
10 Feb, 2018
Event End Date
SPECIALITIES
OncologyDermatologySUGGESTED HOTELS
CONFERENCE VENUE
InterContinental New York Times SquareRELATED CONFERENCES & LIVE WEBINARS
Quick Links